SEARCH

SEARCH BY CITATION

References

  • 1
    Gatti RA, Meuwissen HJ, Allen HD et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968; 2:13661369.
  • 2
    Bach FH, Albertini RJ, Joo P et al. Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968; 2:13641366.
  • 3
    Gocheva L. Total body irradiation prior to bone marrow transplantation; some aspects of fifty year experience. J BUON 2004; 9:147160.
  • 4
    Carella AM. Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: Conditioning regimens with fludarabine. Hematol J 2004;5(Suppl 1):S68S75.
  • 5
    Marmont AM. Stem cell transplantation for autoimmune disorders. Coincidental autoimmune disease in patients transplanted for conventional indications. Best Pract Res Clin Haematol 2004; 17:223232.
  • 6
    Burt RK, Traynor AE. SLE—Hematopoietic stem cell transplantation for systemic lupus erythematosus. Arthritis Res Ther 2003; 5:207209.
  • 7
    Burt RK, Traynor AE. Hematopoietic stem cell transplantation: A new therapy for autoimmune disease. Stem Cells 1999; 17:366372.
  • 8
    Baron F, Storb R. Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders. Mol Ther 2006; 13:2641.
  • 9
    Bregni M, Dodero A, Peccatori J et al. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer. Blood 2002; 99:42344236.
  • 10
    Eibl B, Schwaighofer H, Nachbaur D et al. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood 1996; 88:15011508.
  • 11
    Cutler C, Giri S, Jeyapalan S et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis. J Clin Oncol 2001; 19:36853691.
  • 12
    Bacigalupo A, Lamparelli T, Barbanti M et al. Improved results in marrow transplantation from unrelated donors. Genoa BMT Group. Haematologica 1999;84(suppl EHA-4):5022.
  • 13
    Parody R, Martino R, Rovira M et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006; 12:734748.
  • 14
    Kushida T, Inaba M, Hisha H et al. Intra-bone marrow injection of allogeneic bone marrow cells: A powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 2001; 97:32923299.
  • 15
    Ikehara S. New strategies for BMT, organ transplantation, and regeneration therapy. Hematology 2003; 8:7781.
  • 16
    Esumi T, Inaba M, Ichioka N et al. Successful allogeneic leg transplantation in rats in conjunction with intra-bone marrow injection of donor bone marrow cells. Transplantation 2003; 76:15431548.
  • 17
    Kaneda H, Adachi Y, Saito Y et al. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation. J Heart Lung Transplant 2005; 24:14151423.
  • 18
    Elsdale T, Bard J. Collagen substrata for studies on cell behavior. J Cell Biol 1972; 54:626637.
  • 19
    Okabe M, Ikawa M, Kominami K et al. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett 1997; 407:313319.
  • 20
    Wang YB, Ogawa Y, Doi H et al. Long-term immunologic induction of donor-specific tolerance to skin allografts by bone marrow transplant in rabbits. Plast Reconstr Surg 2003; 111:291297.
  • 21
    Suzuki Y, Adachi Y, Minamino K et al. A new strategy for treatment of malignant tumor: Intra-bone marrow-bone marrow transplantation plus CD4-donor lymphocyte infusion. Stem Cells 2005; 23:365370.
  • 22
    Taira M, Inaba M, Takada K et al. Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells. Transplantation 2005; 79:680687.
  • 23
    Baba S, Inaba M, Iwai H et al. Intra-bone marrow-bone marrow transplantation facilitates hemopoietic recovery including dendritic cells. Immunobiology 2005; 210:3342.
  • 24
    Takada K, Inaba M, Ichioka N et al. Treatment of senile osteoporosis in SAMP6 mice by intra-bone marrow injection of allogeneic bone marrow cells. Stem Cells 2006; 24:399405.
  • 25
    Sugiura K, Inaba M, Hisha H et al. Requirement of major histocompatibility complex-compatible microenvironment for spleen colony formation (CFU-S on day 12 but not on day 8). Stem Cells 1997; 15:461468.
  • 26
    Hashimoto F, Sugiura K, Inoue K et al. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo. Blood 1997; 89:4954.
  • 27
    Wang J, Kimura T, Asada R et al. SCID-repopulating cell activity of human cord blood-derived CD34-cells assured by intra-bone marrow injection. Blood 2003; 101:29242931.